CLINICAL TRIALS PROFILE FOR HYDROXYZINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for hydroxyzine hydrochloride
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00162786 ↗ | Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving Performance | Terminated | J. Uriach and Company | Phase 4 | 2005-05-01 | The primary objective of this study is to measure and compare the acute effects of rupatadine 10 mg, relative to placebo and hydroxyzine 50 mg as an active control on healthy volunteers' performance on a standard over-the-road driving test and a car-following test. |
NCT00202514 ↗ | Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms | Completed | Abbott | Phase 2/Phase 3 | 2004-09-01 | The purpose of this study is to test the safety and effectiveness of an extended release form of a medication called divalproex sodium (Depakote ER) for the treatment of people with alcohol dependence who have mood and/or anxiety symptoms. This medication has helped reduce symptoms of acute alcohol withdrawal as well as stabilize mood symptoms in bipolar disorder and other mental health disorders. This study will test the hypothesis that divalproex sodium will help reduce mood and anxiety symptoms during early abstinence from alcohol and in turn reduce relapse and craving for alcohol. |
NCT00202514 ↗ | Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms | Completed | Seattle Institute for Biomedical and Clinical Research | Phase 2/Phase 3 | 2004-09-01 | The purpose of this study is to test the safety and effectiveness of an extended release form of a medication called divalproex sodium (Depakote ER) for the treatment of people with alcohol dependence who have mood and/or anxiety symptoms. This medication has helped reduce symptoms of acute alcohol withdrawal as well as stabilize mood symptoms in bipolar disorder and other mental health disorders. This study will test the hypothesis that divalproex sodium will help reduce mood and anxiety symptoms during early abstinence from alcohol and in turn reduce relapse and craving for alcohol. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for hydroxyzine hydrochloride
Condition Name
Clinical Trial Locations for hydroxyzine hydrochloride
Trials by Country
Clinical Trial Progress for hydroxyzine hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for hydroxyzine hydrochloride
Sponsor Name
Sponsor Name for hydroxyzine hydrochloride | |
Sponsor | Trials |
University Hospital, Clermont-Ferrand | 2 |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
Seattle Institute for Biomedical and Clinical Research | 1 |
[disabled in preview] | 0 |
This preview shows a limited data set Subscribe for full access, or try a Trial |